- Set up a radiopharmaceutical spin off, Ysotope Theragnostics
- We were included in different national networks focused in imaging and tech transfer (Diamond, X4HPC)
- We have been awarded 4 EU projects with important roles as WP leaders in each one
- Several studies focused on imaging have performed and published during this period
- We have developed several radiopharmaceuticals for oncology with high transfer potential
eCORE
- Advanced Therapies and Advanced Interventions, Nanomedicine, Transplant & Donation
- Chronic, Prevalent Diseases & Aging
- Personalized Medicine, Innovative Diagnostics, Molecular Imaging & Digital Health
Team
Group Leader
José Raul Herance Camacho
Principal Investigator (PI)
Santiago Aguade Bruix, Xavier Serres Créixams, Ana Maria Rodriguez Arana, Julia Baguña Torres. Manuel Escobar Amores
Researchers
Cristina Gámez Cenzano, Maria Nazarena Pizzi, Cuellar Calabria, Hug, Roque Pérez, Albert, Diego A Villasboas Rosciolesi, Joan Castell Conesa, Marc Simó Perdigó, Carles Lorenzo Bosquet, Gemma Cuberas Borros, Juan Pablo Salazar Gutierrez, Gemma Burcet Rodríguez, Fiorella Dellepiane Clarke, Ignacio Navales Mateu, Mª Jose Moreno Negreie, Mº Teresa Veintemillas Araiz, Daniel Eiroa Gutierrez, Mònica Velasco Nuño, Erique Franky, Eser Ucar, Martha Sahyli Ortega Pijeira, Esperanza Medina Gutiérrez, Nuria Roson Gradaille, Jorge Guillermo Romero Farina, Maria Boronat Ferrater, Marta Barios Profitos, Amparo García Burillo, Almudena Maceda Garcia
PhD Students
Mª Àngels Hernández Fructuoso, Beatriz Santos Montero, Marina Llenas Martinez, Clara Ramirez Serra, Carina Espinet Coll, Queralt Martin Saladich, Álvaro Valverde Moya, Carolina Aparicio Gómez, Carmen Gloria Franco Monterroso, Emily Betancourt, Sofia Rodríguez, Nuria Rosón
Lab Technicians
Irati Caballero Bermejo, Itziar Busquets Sáez
Nursing and Technical Staff
Eduard Albuixech Ginesta, Maria Eva Castillo Martinez, Inés Carolina Balón Llerena, Joan Barbeta Sanchez, Miguel Descalzo Pérez, Lluís Gabalda Martínez, Héctor García Fernández, Mireia Iniesta Ambrós, Julio Linares Molina, Mª Carmen López Arribas, Sergio López Gandu, Carmen Sanchez Suarez
Publications
Martín-Saladich Q, Simó R, Aguadé-Bruix S, Simó-Servat O, Aparicio-Gómez C, Hernández C, Ramirez-Serra C, Pizzi MN, Roque A, González Ballester MA, Herance JR
Insights into Insulin Resistance and Calcification in the Myocardium in Type 2 Diabetes: A Coronary Artery Analysis
Int J Mol Sci. 2023 ;24(4):3250
DOI: 10.3390/ijms24043250
IF: 5.6
Herance JR, Ciudin A, Lamas-Domingo R, Aparicio-Gómez C, Hernández C, Simó R, Palomino-Schätzlein M
The Footprint of Type 1 Diabetes on Red Blood Cells: A Metabolomic and Lipidomic Study
J Clin Med. 2023;12(2):556
DOI: 10.3390/jcm12020556
IF: 3.0
Barreiro-Pérez M, Cabeza B, Calvo D, Reyes-Juárez JL, Datino T, Vañó Galván E, Maceira González AM, Delgado Sánchez-Gracián C, Prat-González S, Perea RJ, Bastarrika G, Sánchez M, Jiménez-Borreguero LJ, Fernández-Golfín Lobán C; Expert reviewers:; Rodríguez Palomares JF, Tolosana JM, Hidalgo Pérez JA, Pérez-David E, Bertomeu-González V, Cuéllar H
Magnetic resonance in patients with cardiovascular devices. SEC-GT CRMTC/SEC-Heart Rhythm Association/SERAM/SEICAT consensus document
Rev Esp Cardiol (Engl Ed). 2023 Mar;76(3):183-196
DOI: 10.1016/j.rec.2022.12.002
IF: 5.9
Guillermo Romero-Farina, Santiago Aguadé-Bruix, Ignacio Ferreira González
Vall d'Hebron Risk Score II for myocardial infarction and cardiac death
Open Heart . 2023;10(2):e002431
DOI: 10.1136/openhrt-2023-002431
IF: 2.8
Patricia O'Gorman, Lawrence Nair, Nadya Kisiel, Ian Hughes, Karen Huang, Charlie Chia-Tsong Hsu, Erika Fagman, Ruth Heying, María N Pizzi, Albert Roque, Kuljit Singh
Meta-analysis assessing the sensitivity and specificity of 18F-FDG PET/CT for the diagnosis of prosthetic valve endocarditis (PVE) using individual patient data (IPD)
Am Heart J. 2023:261:21-34
DOI: 10.1016/j.ahj.2023.03.004
IF: 5.1
Projects
Immune-Image: Specific Imaging of Immune Cell Dynamics Using Novel Tracer Strategies
Principal Investigator: Raul Herance
Agency: EU-IMI2
Funding: 514,560 €
Period: 01/10/2019 - 30/09/2024
Insulin resistance in type 2 diabetes: unraveling the pathogenic mechanism between organs
Principal Investigator: J Raul Herance
Agency: Instituto de Salud Carlos III
Funding: 159,720 €
Period: 01/01/2021 - 30/06/2025
Early molecular nanoDIAGnostics of Brain tumors using Immune-PET (DIAGBI)
Principal Investigator: J Raul Herance
Agency: Ministerio de Ciencia e Innovación-MICINN
Funding: 216,102 €
Period: 01/10/2021 - 30/09/2024
PHASE IV AI: Privacy compliant health data as a service for AI development
Principal Investigator: Manuel Escobar
Agency: European Commission
Funding: 207,500 €
Period: 01/10/2023 - 30/09/2026
QUSTom - Quantitative Ultrasound Stochastic Tomography - Revolutionizing breast cancer diagnosis and screening with supercomputing-based radiation-free imaging
Principal Investigator: Ana Maria Rodriguez Arana
Agency: European Commission
Funding: 400,871.25 €
Period: 01/04/2022 - 30/09/2024
